Parsatuzumab

Parsatuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)).

Trade Name Parsatuzumab
Generic Parsatuzumab
Parsatuzumab Other Names MEGF0444A, Parsatuzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Parsatuzumab
Parsatuzumab

Innovators Monograph

You find simplified version here Parsatuzumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share